Chemical pleuritis as the cause of acute chest pain following high-dose methotrexate treatment

Cancer. 1983 Jan 1;51(1):34-7. doi: 10.1002/1097-0142(19830101)51:1<34::aid-cncr2820510109>3.0.co;2-s.

Abstract

This report describes the clinical and roentgenographic features of a pleuritis seen following the administration of high-dose methotrexate (HDMTX). Among 210 patients who received 3130 courses of HDMTX from 1977 through 1980, the incidence of this clinical entity was 8.5% (n = 18). The sudden onset of chest pain occurred only after the third or fourth HDMTX treatment and usually lasted between three and five days; the pain was often quite severe and led to extensive clinical examination before recognition of the benign transient nature of this syndrome. Roentgenographic examination of the chest revealed thickening of the intralobar pleura, most prominent on the right side. Our observations support the hypothesis that this adverse drug reaction occurs more frequently than assumed, but is often ignored or misinterpreted.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Diagnosis, Differential
  • Female
  • Humans
  • Leukemia / drug therapy
  • Male
  • Methotrexate / adverse effects*
  • Pain / etiology*
  • Pleurisy / chemically induced*
  • Pleurisy / complications
  • Pleurisy / diagnostic imaging
  • Pneumothorax / chemically induced
  • Pneumothorax / complications
  • Radiography
  • Thorax*

Substances

  • Methotrexate